Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-01-30

Clinical Trial Update: Registry Study for the Observation of Patients With ESUS/Cryptogenic Stroke

View source ↗

Summary

An observational registry study is being conducted to monitor patients with embolic stroke of undetermined source (ESUS) or cryptogenic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ludwig-Maximilians - University of Munich | Conditions: Embolic Stroke of Undetermined Source | Status: UNKNOWN